1. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

   • Christopher C. Benz
   • Gary K. Scott
   • C. Kent Osborne

   Report Pages: 85 - 95

2. C-erbB-2 protein in the sera of breast cancer patients

   • Tatsuhiko Narita
   • Hiroomi Funahashi
   • Hiroshi Takagi

   Report Pages: 97 - 102

3. Epitope expression on the breast epithelial mucin

   • Roberto L. Ceriani
   • Jerry A. Peterson
   • Derek T. A. Lamport

   Report Pages: 103 - 113

4. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas — a 10 year survival study

   • Sven-Börje Ewers
   • Robyn Attewell
   • Dick Killander

   Report Pages: 115 - 126

5. Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate

   • Shengmin Li
   • Martin Lepage
   • Fernand Labrie

   Report Pages: 127 - 137

6. Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen

   • E. Garcia-Giralt
   • Y. Ayme
   • D. Zylberait

   Report Pages: 139 - 145

7. Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor

   • Slobodan R. Milovanovic
   • Sinisa Radulovic
   • Andrew V. Schally

   Report Pages: 147 - 158

8. Hereditary breast cancer in sweden: a predominance of maternally inherited cases

   • Annika Lindblom
   • Sam Rotstein
   • Lennart Iselius

   Report Pages: 159 - 165

9. Lipid-associated sialic acid levels in human breast cyst fluids

   • Ferdinando Mannello
   • GianDomenico Bocchiotti
   • Giancarlo Gazzanelli

   Brief Communication Pages: 167 - 170